WuXi STA

About WuXi STA

WuXi STA, a subsidiary of WuXi AppTec, is a leading CRDMO providing integrated CMC services including both API and drug product for small molecule, oligonucleotide, peptide and complex conjugate from discovery to development and commercial manufacturing. We have 14 R&D and manufacturing sites across Asia, North America and Europe. 

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Contact info
  • 6114 Nancy Ridge Drive, 92121, San Diego, California, United States
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from WuXi STA (5)

  • Pre-formulation development

    Product Pre-formulation development

    WuXi STA's IND Enabling Preformulation Package (IEPP) is an integrated end-to-end developability assessment service for new chemical entities (NCE). Efficiently identify challenges and solutions earlier for higher success rates and lower overall costs. PK formulation, Profiling, Form selection, and&nb...
  • Bioavailability enhancement and advanced delivery technologies

    Product Bioavailability enhancement and advanced delivery technologies

    Bioavailability Toolbox:Spray-dried dispersion (SDD) - preclinical to commercial scale
    Hot melt extrusion (HME)
    Nano suspension
    Softgel & Liquid filled capsules
    Injectable
  • Peptide Process Development and Manufacturing

    Product Peptide Process Development and Manufacturing

    WuXi STA Peptide platform services include: Process R&D, Manufacturing grams to kilograms peptides under cGMP, Analytical characterization, method development and validation, IPC & release testing, ICH compliant stability studies, Regulatory (CMC) submission support. Our platform support a wide var...
  • Oligonucleotide Process Development and Manufacturing

    Product Oligonucleotide Process Development and Manufacturing

    WuXi STA has an integrated Oligo API process R&D and manufacturing platform from preclinical to commercial, operating at our US FDA inspected integrated process R&D and manufacturing facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modal...
  • Highly potent API and ADC payload and payload-linker manufacturing

    Product Highly potent API and ADC payload and payload-linker manufacturing

    WuXi STA's Jinshan site and WuXi STA's Changzhou site are equipped with a R&D labs, a cGMP HP Kilo lab, and cGMP plant for handling highly potent APIs (HPAPIs) and antibody drug conjugate (ADC) payloads and payload-linkers. We offer drug product manufacturing at STA’s Shanghai Waiga...

WuXi STA Resources (4)